Advisor Group Holdings, Inc. Fortress Biotech, Inc. Transaction History

Advisor Group Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.48 - $0.88 $7,608 - $13,948	-15,851 Reduced 56.21%	12,350 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.79 - $22.0 $4,931 - $137,324	6,242 Added 28.43%	28,201 $24,000
Q2 2022 Aug 10, 2022	BUY	$0.8 - $1.5 $1,551 - $2,908	1,939 Added 9.69%	21,959 $18,000
Q1 2022 May 04, 2022	BUY	$1.24 - $2.75 $21,352 - $47,355	17,220 Added 615.0%	20,020 $27,000
Q3 2021 Nov 05, 2021	SELL	$2.82 - $3.7 $2,820 - $3,700	-1,000 Reduced 26.32%	2,800 $9,000

Q2 2021 Aug 02, 2021	SELL	$3.5 - $5.48 $11,200 - $17,536	-3,200 Reduced 45.71%	3,800 $13,000
Q4 2020 Feb 10, 2021	SELL	$2.2 - $4.45 $37,131 - $75,107	-16,878 Reduced 70.68%	7,000 $22,000
Q3 2020 Nov 12, 2020	BUY	$2.62 - $4.78 $31,440 - $57,360	12,000 Added 101.03%	23,878 $96,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $3.16 $16,217 - $28,003	8,862 Added 293.83%	11,878 $31,000
Q1 2020 May 18, 2020	BUY	$1.14 - $2.96 $3,438 - $8,927	3,016 New	3,016 $6,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.